Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 1/2020

01-01-2020 | Health Services Research and Global Oncology

Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores

Authors: Joseph D. Phillips, MD, Sandra L. Wong, MD, MS

Published in: Annals of Surgical Oncology | Issue 1/2020

Login to get access

Abstract

Traditional measures of quality and effectiveness in surgical oncology have focused on morbidity, mortality, and when available, recurrence rates. Measuring patient-reported outcomes (PROs) has become more widely accepted during the last decade. This article reviews instruments commonly used in the surgical treatment of cancer patients to evaluate PROs. In addition, it discusses the linkage of PROs and health-related quality of life measures with traditional surgical complications and highlights future directions related to the expanding use of PROs in the surgical care of cancer patients.
Literature
1.
2.
3.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:7–30.PubMedCrossRef
4.
Waljee JF, Dimick JB. Do patient-reported outcomes correlate with clinical outcomes following surgery? Adv Surg. 51 2017;141–50.PubMedCrossRef
5.
Committee on Quality Health Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st Century. Washington DC, National Academy Press, 2001.
6.
7.
Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7:903–9.PubMedCrossRef
8.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273:59–65.CrossRefPubMed
9.
Korolija D, Wood-Dauphinee S, Pointner R. Patient-reported outcomes: how important are they? Surg Endosc. 2007;21:503–7.PubMedCrossRef
10.
Pezold ML, Pusic AL, Cohen WA, Hollenberg JP, Butt Z, Flum DR, Temple LK. Defining a research agenda for patient-reported outcomes in surgery: using a Delphi survey of stakeholders. JAMA Surg. 2016;151:930–6.PubMedPubMedCentralCrossRef
11.
12.
Bilimoria KY, Cella D, Butt Z. Current challenges in using patient-reported outcomes for surgical care and performance measurement: everybody wants to hear from the patient, but are we ready to listen? JAMA Surg. 2014;149:505–6.PubMedCrossRef
13.
Pusic A, Liu JC, Chen CM, Cano S, Davidge K, Klassen A, et al. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2007;136:525–35.PubMedCrossRef
14.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
15.
Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care. 1988;26:724–35.PubMedCrossRef
16.
Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981;34:585–97.PubMedCrossRef
17.
EuroQol G. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef
18.
Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33:328–36.PubMedCrossRef
19.
Straatman J, Joosten PJ, Terwee CB, Cuesta MA, Jansma EP, van der Peet DL. Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer. Dis Esophagus. 2016;29:760–72.PubMedCrossRef
20.
Straatman J, van der Wielen N, Joosten PJ, Terwee CB, Cuesta MA, Jansma EP, van der Peet DL. Assessment of patient-reported outcome measures in the surgical treatment of patients with gastric cancer. Surg Endosc. 2016;30:1920–9.PubMedCrossRef
21.
Ilonen IK, Rasanen JV, Knuuttila A, Sihvo EI, Sintonen H, Sovijarvi AR, Salo JA. Quality of life following lobectomy or bilobectomy for non-small cell lung cancer: a two-year prospective follow-up study. Lung Cancer. 2010;70:347–51.PubMedCrossRef
22.
Garcia SF, Cella D, Clauser SB, Flynn KE, Lad T, Lai JS, et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007;25:5106–12.PubMedCrossRef
23.
Khullar OV, Fernandez FG. Patient-reported outcomes in thoracic surgery. Thorac Surg Clin. 2017;27:279–90.PubMedCrossRef
24.
Jones RS, Stukenborg GJ. Patient-reported Outcomes Measurement Information System (PROMIS) use in surgical care: a scoping study. J Am Coll Surg. 2017;224:245–54 e1.
25.
Hedrick TL, Harrigan AM, Thiele RH, Friel CM, Kozower BD, Stukenborg GJ. A pilot study of patient-centered outcome assessment using PROMIS for patients undergoing colorectal surgery. Support Care Cancer. 2017;25:3103–12.PubMedPubMedCentralCrossRef
26.
Khullar OV, Rajaei MH, Force SD, Binongo JN, Lasanajak Y, Robertson S, et al. Pilot study to integrate patient reported outcomes after lung cancer operations into the Society of Thoracic Surgeons database. Ann Thorac Surg. 2017;104:245–53.PubMedCrossRef
27.
Blank AT, Lerman DM, Shaw S, Dadrass F, Zhang Y, Liu W. PROMIS((R)) scores in operative metastatic bone disease patients: a multicenter, prospective study. J Surg Oncol. 2018;118:532–5.PubMed
28.
Reeve BB, Wang M, Weinfurt K, Flynn KE, Usinger DS, Chen RC. Psychometric evaluation of PROMIS sexual function and satisfaction measures in a longitudinal population-based cohort of men with localized prostate cancer. J Sex Med. 2018;15:1792–810.PubMedPubMedCentralCrossRef
29.
Doll KM, Barber EL, Bensen JT, Revilla MC, Snavely AC, Bennett AV, et al. The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: a prospective longitudinal cohort study. Am J Obstet Gynecol. 2016;215:457 e1–457 e13.PubMedPubMedCentral
30.
Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995;82:216–22.PubMedCrossRef
31.
Svedlund J, Sjodin I, Dotevall G. GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–34.PubMedCrossRef
32.
Van Nieveendijkum EJ, Terwee CB, Oosterveld P, Van Der Meulen JH, Gouma DJ, De Haes JC. Validation of the gastrointestinal quality-of-life index for patients with potentially operable periampullary carcinoma. Br J Surg. 2000;87:110–5.CrossRef
33.
Kulich KR, Madisch A, Pacini F, Pique JM, Regula J, Van Rensburg CJ, et al. Reliability and validity of the gastrointestinal symptom rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12.PubMedPubMedCentralCrossRef
34.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al., The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.PubMedCrossRef
35.
Gazala S, Pelletier JS, Storie D, Johnson JA, Kutsogiannis DJ, Bedard EL. A systematic review and meta-analysis to assess patient-reported outcomes after lung cancer surgery. Sci World J. 2013;2013:789625.CrossRef
36.
Pompili C, Velikova G, White J, Callister M, Robson J, Dixon S, et al. Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer. Eur J Cardiothorac Surg. 2017;51:526–31.PubMed
37.
Soo Hoo S, Marriott N, Houlton A, Nevin J, Balega J, Singh K, et al. Patient-reported outcomes after extensive (ultraradical) surgery for ovarian cancer: results from a prospective longitudinal feasibility study. Int J Gynecol Cancer. 2015;25:1599–607.PubMedCrossRef
38.
Cowan RA, Suidan RS, Andikyan V, Rezk YA, Einstein MH, Chang K, et al. Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: a prospective study measuring symptoms and health-related quality of life. Gynecol Oncol. 2016;143:362–6.PubMedPubMedCentralCrossRef
39.
Boyes H, Barraclough J, Ratansi R, Rogers SN, Kanatas A. Structured review of the patient-reported outcome instruments used in clinical trials in head and neck surgery. Br J Oral Maxillofac Surg. 2018;56:161–7.PubMedCrossRef
40.
Kupsch J, Kuhn M, Matzel KE, Zimmer J, Radulova-Mauersberger O, Sims A, et al. To what extent is the low anterior resection syndrome (LARS) associated with quality of life as measured using the EORTC C30 and CR38 quality-of-life questionnaires? Int J Colorectal Dis. 2019;34:747–62.PubMedCrossRef
41.
Babin E, Sigston E, Hitier M, Dehesdin D, Marie JP, Choussy O. Quality of life in head and neck cancers patients: predictive factors, functional, and psychosocial outcome. Eur Arch Otorhinolaryngol. 2008;265:265–70.PubMedCrossRef
42.
Lagendijk M, van Egdom LSE, Richel C, van Leeuwen N, Verhoef C, Lingsma HF, Koppert LB. Patient-reported outcome measures in breast cancer patients. Eur J Surg Oncol. 2018;44:963–8.PubMedCrossRef
43.
Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89:1634–46.PubMedCrossRef
44.
Shi Q, Wang XS, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS. Patient-reported symptom interference as a measure of postsurgery functional recovery in lung cancer. J Pain Symptom Manag. 2016;52:822–31.CrossRef
45.
Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol 2018;149:484–90.PubMedPubMedCentralCrossRef
46.
Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY. Patient-reported outcomes are associated with enhanced recovery status in patients with bladder cancer undergoing radical cystectomy. Surg Innov. 2018;25:242–50.PubMedPubMedCentralCrossRef
47.
Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, et al. Comparison of patient-reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs interval tumor reductive surgery. Gynecolo Oncol. 2019;152:501–8.CrossRef
48.
Day RW, Cleeland CS, Wang XS, Fielder S, Calhoun J, Conrad C, et al. Patient-reported outcomes accurately measure the value of an enhanced recovery program in liver surgery. J Am Coll Surg. 2015;221:1023–30 e1-2.
49.
de Haes JC, van Knippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990;62:1034–8.PubMedPubMedCentralCrossRef
50.
Montazeri A, McEwen J, Gillis CR. Quality of life in patients with ovarian cancer: current state of research. Support Care Cancer. 1996;4:169–79.PubMedCrossRef
51.
Kovacic T, Kovacic M. Impact of relaxation training according to Yoga In Daily Life(R) system on perceived stress after breast cancer surgery. Integr Cancer Ther. 2011;10:16–26.PubMedCrossRef
52.
Hall A, A’Hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer. 1999;35:79–85.PubMedCrossRef
53.
van Heijl M, Sprangers MA, de Boer AG, Lagarde SM, Reitsma HB, Busch OR, et al. Preoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer. Ann Surg Oncol. 2010;17:23–30.PubMedCrossRef
54.
de Boer AG, van Lanschot JJ, van Sandick JW, Hulscher JB, Stalmeier PF, de Haes JC, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 2004;22:4202–8.PubMedCrossRef
55.
De Boer AG, Genovesi PI, Sprangers MA, Van Sandick JW, Obertop H, Van Lanschot JJ. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg. 2000;87:1716–21.PubMedCrossRef
56.
Ribi K, Bernhard J, Schuller JC, Weder W, Bodis S, Jorger M; Swiss Group for Clinical Cancer Research. Individual versus standard quality-of-life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer. 2008;61:398–404.PubMedCrossRef
57.
Allen-Mersh TG, Glover C, Fordy C, Henderson DC, Davies M. Relation between depression and circulating immune products in patients with advanced colorectal cancer. J R Soc Med. 1998;91:408–13.PubMedPubMedCentralCrossRef
58.
Davies J, Johnston D, Sue-Ling H, Young S, May J, Griffith J, et al. Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg. 1998;22:1048–55.PubMedCrossRef
59.
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–9.PubMedCrossRef
60.
Christensen JF, Simonsen C, Banck-Petersen A, Thorsen-Streit S, Herrstedt A, Djurhuus SS, et al. Safety and feasibility of preoperative exercise training during neoadjuvant treatment before surgery for adenocarcinoma of the gastro-oesophageal junction. BJS Open. 2019;3:74–84.PubMedCrossRef
61.
Palma DA, Nguyen TK, Louie AV, Malthaner R, Fortin D, Rodrigues GB, et al. Measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage non-small cell lung cancer: a phase 2 clinical trial. JAMA Oncol. 2019;5:681–88.PubMedPubMedCentralCrossRef
62.
Lee HH, Chiu CC, Lin JJ, Wang JJ, Lee KT, Sun DP, Shi HY. Impact of preoperative anxiety and depression on quality of life before and after resection of hepatocellular carcinoma. J Affect Disord. 2019;246:361–7.PubMedCrossRef
63.
Sato N, Hasegawa Y, Saito A, Motoi F, Ariake K, Katayose Y, et al. Association between chronological depressive changes and physical symptoms in postoperative pancreatic cancer patients. Biopsychosoc Med. 2018;12:13.PubMedPubMedCentralCrossRef
64.
Delaloge S, Cella D, Ye Y, Buyse M, Chan A, Barrios CH, et al. Effects of neratinib on health-related quality-of-life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. Ann Oncol. 2019;30:567–74.PubMedCrossRef
65.
Downing A, Glaser AW, Finan PJ, Wright P, Thomas JD, Gilbert A, et al. Functional outcomes and health-related quality of life after curative treatment for rectal cancer: a population-level study in England. Int J Radiat Oncol Biol Phys. 2018;103:1132–42.PubMedCrossRef
66.
Iravani K, Jafari P, Akhlaghi A, Khademi B. Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy. Health Qual Life Outcomes. 2018;16:183.PubMedPubMedCentralCrossRef
67.
Dellabella M, Branchi A, Gasparri L, Claudini R, Castellani D. Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial. World J Urol. 2018;36:1629–34.PubMedCrossRef
68.
69.
Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106:dju244.PubMedPubMedCentralCrossRef
70.
71.
72.
Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, et al. Feasibility of patient reporting of symptomatic adverse events via the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a chemoradiotherapy cooperative group multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2017;98:409–18.PubMedPubMedCentralCrossRef
73.
Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, et al. Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse Events in a multicenter trial: NCCTG N1048. J Clin Oncol. 2018;36:3120–25.CrossRefPubMedCentral
74.
Chung AE, Shoenbill K, Mitchell SA, Dueck AC, Schrag D, Bruner DW, Minasian LM, et al. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Am Med Inform Assoc. 2019;26:276–85.PubMedPubMedCentralCrossRef
75.
Ancker JS, Stabile C, Carter J, Chen LY, Stein D, Stetson PD, Vickers AJ, et al. Informing, reassuring, or alarming? Balancing patient needs in the development of a postsurgical symptom reporting system in cancer. AMIA Annu Symp Proc. 2018;2018:166–74.PubMedPubMedCentral
76.
Liu JB, Pusic AL, Matroniano A, Aryal R, Willarson PB, Hall BL, et al. First report of a multiphase pilot to measure patient-reported outcomes in the American College of Surgeons National Surgical Quality Improvement Program. Jt Comm J Qual Patient Saf. 2018;45:319–28.PubMed
77.
Tevis SE, James TA, Kuerer HM, Pusic AL, Yao KA, Merlino J, Dietz J. Patient-reported outcomes for breast cancer. Ann Surg Oncol. 2018;25:2839–45.PubMedCrossRef
78.
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124:345–53.PubMedCrossRef
79.
Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Breast cancer and reconstruction: normative data for interpreting the BREAST-Q. Plast Reconstr Surg. 2017;139:1046e–55e.PubMedPubMedCentralCrossRef
80.
Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surv. 2015;9:68–79.CrossRef
81.
Buchanan PJ, Abdulghani M, Waljee JF, Kozlow JH, Sabel MS, Newman LA, et al. An analysis of the decisions made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg. 2016;138:29–40.PubMedCrossRef
82.
Jay M, Creelman B, Baliski C. Patient-reported outcomes associated with surgical intervention for breast cancer. Am J Surg. 2019. Epub ahead of print.
83.
Bakx R, Sprangers MA, Oort FJ, van Tets WF, Bemelman WA, Slors JF, van Lanschot JJ. Development and validation of a colorectal functional outcome questionnaire. Int J Colorectal Dis. 2005;20:126–36.PubMedCrossRef
84.
Thyo A, Emmertsen KJ, Pinkney TD, Christensen P, Laurberg S. The colostomy impact score: development and validation of a patient-reported outcome measure for rectal cancer patients with a permanent colostomy: a population-based study. Colorectal Dis. 2017;19:O25–33.PubMedCrossRef
85.
Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922–8.PubMedCrossRef
86.
Pieniowski EHA, Palmer GJ, Juul T, Lagergren P, Johar A, Emmertsen KJ, et al. Low Anterior resection syndrome and quality of life after sphincter-sparing rectal cancer surgery: a long-term longitudinal follow-up. Dis Colon Rectum. 2019;62:14–20.PubMedCrossRef
87.
Allvin R, Ehnfors M, Rawal N, Svensson E, Idvall E. Development of a questionnaire to measure patient-reported postoperative recovery: content validity and intra-patient reliability. J Eval Clin Pract. 2009;15:411–9.PubMedCrossRef
88.
Jakobsson J, Idvall E, Kumlien C. Patient characteristics and surgery-related factors associated with patient-reported recovery at 1 and 6 months after colorectal cancer surgery. Eur J Cancer Care Engl. 2017;26:e12715.CrossRef
89.
Nakamura M, Kido Y, Yano M, Hosoya Y. Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal carcinoma. Surg Today. 2005;35:535–42.PubMedCrossRef
90.
Korenaga D, Orita H, Okuyama T, Moriguchi S, Maehara Y, Sugimachi K. Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg. 1992;79:248–50.PubMedCrossRef
91.
Wu CW, Hsieh MC, Lo SS, Lui WY, P’Eng FK. Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg. 1997;21:777–82.PubMedCrossRef
92.
Smith AB, Basch E. Role of patient-reported outcomes in postsurgical monitoring in oncology. J Oncol Pract. 2017;13:535–8.PubMedCrossRef
93.
Waljee JF, Ghaferi A, Finks JF, Cassidy R, Varban O, Carlin A, et al. Variation in patient-reported outcomes across hospitals following surgery. Med Care. 2015;53:960–6.PubMedCrossRef
94.
Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, et al. Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol. 2014;133:546–51.PubMedPubMedCentralCrossRef
95.
Fink CA, Friedrich M, Frey PE, Radeker L, Leuck A, Bruckner T, et al. Prospective multicentre cohort study of patient-reported outcomes and complications following major abdominal neoplastic surgery (PATRONUS): study protocol for a CHIR-Net student-initiated German medical audit study (CHIR-Net SIGMA study). BMC Surg. 2018;18:90.PubMedPubMedCentralCrossRef
Metadata
Title
Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores
Authors
Joseph D. Phillips, MD
Sandra L. Wong, MD, MS
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 1/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07752-7

Other articles of this Issue 1/2020

Annals of Surgical Oncology 1/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Recurrence Patterns After Surgical Treatment of Pseudomyxoma Peritonei From Low-Grade Appendiceal Mucinous Neoplasms

Peritoneal Surface Malignancy

Preoperative Radiographic Assessment Predicts Incomplete Cytoreduction in Patients with Low Grade Mucinous Adenocarcinoma of the Appendix

Peritoneal Surface Malignancy

Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors

Melanoma

The Landmark Series: Non-melanoma Skin Cancers

Gastrointestinal Oncology

Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review

Peritoneal Surface Malignancy

50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience